Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

Stopped Accrual and treatment with CG1940/CG8711 stopped due to IDMC recommendation.

Conditions

• Prostate Cancer

Interventions

• BIOLOGICAL: Immunotherapy allogeneic GM-CSF secreting cellular vaccine
• DRUG: Chemotherapy (docetaxel and prednisone)

Sponsor

Cell Genesys